President of the Republic of Lithuania President of the Republic of Lithuania

The President: Lithuania contributes significantly to EU vaccine production


President Gitanas Nausėda met with the EU Commissioner for Internal Market, Thierry Breton, to discuss the production of vaccines and their supply chain.

The President emphasized the potential of the Lithuanian life sciences industry and its capacity to make a significant contribution to the production of vaccines in the EU. “Lithuania’s life sciences sector grew by 14 percent over the last year and accounted for about 2 percent of the national GDP. We have the necessary science and business infrastructure as well as human talent. Our companies are already contributing to the production of vaccines in the EU and they are ready to become a meaningful part of the EU life sciences industry,” the President said.

The meeting also addressed the European Union’s technological potential and its development, with special focus on digitalization, cyber security and strengthening the transatlantic bond in this area. The President introduced the Commissioner to Lithuania’s decision to develop the 5G network only based on the technologies developed and registered in the EU.

Gitanas Nausėda highlighted Lithuania’s prospects to work in areas funded by the European Defense Fund and the European Space Agency. “Lithuania can make a significant contribution to space research via laser and nano-satellite technologies,” the President said, adding they agreed with the Commissioner that the European Commission would support the establishment of a business incubator in Lithuania for companies engaged in space exploration.  

The President‘s Communication Group

Last updated 2021.05.31 15:33